EGFR and cancer: Of relevance, PKCδ represents one of the immune rheostats responsible for the establishment of non-inflamed phenotype in EGFR-mutated lung cancer, also by increasing the expression of PD-1 ligand PD-L1 on tumor cells [308], leading to immune exclusion and cancer escape from T cell surveillance.